Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24524N0887
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Belle Isle, FL 32809, USA
Award details come from SAM.gov/FPDS.
About this award
On September 4, 2024, the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 5, awarded a delivery order valued at $12,559.90 to Otsuka America Pharmaceutical Inc. for JYNARQUE (tolvaptan) 90mg/30mg tablets. This firm-fixed price delivery order, with an ultimate completion date of September 10, 2024, was issued without a set-aside designation and represents a task order under the company's existing Blanket Purchase Agreement for Jynarque issued by the VA's National Acquisition Center. The product will be delivered to Belle Isle, Florida.
This delivery order exemplifies the VA's ongoing procurement of specialty pharmaceuticals through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is a leading federal contractor for Jynarque, a medication prescribed to treat autosomal dominant polycystic kidney disease and hyponatremia in veterans. The company maintains substantial indefinite delivery vehicles with the VA, including an $83.3 billion blanket purchase agreement, enabling efficient distribution of this critical therapeutic treatment across multiple Veterans Integrated Service Networks nationwide.
Quick answers
Who was awarded contract 36C24524N0887?
36C24524N0887 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 4, 2024.
How much is contract 36C24524N0887 worth?
The government has obligated $12,560 on 36C24524N0887.
Is contract 36C24524N0887 an order under another contract?
Yes. 36C24524N0887 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0887 competed?
The extent of competition for 36C24524N0887 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award